Citius Pharmaceuticals Ownership | Who Owns Citius Pharmaceuticals?


OverviewForecastRevenueFinancialsChart

Citius Pharmaceuticals Ownership Summary


Citius Pharmaceuticals is owned by 8.44% institutional investors, 2.90% insiders, and 88.67% retail investors. Heights capital management is the largest institutional shareholder, holding 1.45% of CTXR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.60% of its assets in Citius Pharmaceuticals shares.

CTXR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCitius Pharmaceuticals8.44%2.90%88.67%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Heights capital management159.90K1.45%$254.24K
Blackrock1.81M1.14%$1.05M
Northern trust1.06M0.66%$615.83K
Blackrock funding, inc. /de69.85K0.63%$111.06K
Newedge advisors25.00K0.23%$39.75K
Xtx topco20.15K0.18%$32.03K
Arkadios wealth advisors20.00K0.18%$31.80K
Bay colony advisory group, inc d/b/a bay colony advisors16.50K0.15%$26.23K
Bank of america corp /de/159.42K0.10%$92.94K
Chelsea counsel4.63K0.04%$7.36K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Heights capital management159.90K0.07%$254.24K
Chelsea counsel4.63K0.00%$7.36K
Bay colony advisory group, inc d/b/a bay colony advisors16.50K0.00%$26.23K
Xtx topco20.15K0.00%$32.03K
Arkadios wealth advisors20.00K0.00%$31.80K
Newedge advisors25.00K0.00%$39.75K
Northern trust1.06M0.00%$615.83K
Legal & general group---
Wr wealth planners---
Geode capital management---

Top Buyers

HolderShares% AssetsChange
Heights capital management159.90K0.07%159.90K
Bank of america corp /de/159.42K-107.23K
Newedge advisors25.00K0.00%25.00K
Citadel advisors24.70K-24.70K
Xtx topco20.15K0.00%20.15K

Top Sellers

HolderShares% AssetsChange
Armistice capital---7.28M
Blackrock1.81M--6.92M
Vanguard group---6.44M
Geode capital management---1.88M
Millennium management---1.16M

New Positions

HolderShares% AssetsChangeValue
Heights capital management159.90K0.07%159.90K$254.24K
Newedge advisors25.00K0.00%25.00K$39.75K
Xtx topco20.15K0.00%20.15K$32.03K
Macquarie group6.89K-6.89K$4.02K
Russell investments group5.46K-5.46K$3.19K

Sold Out

HolderChange
Eversource wealth advisors-16.00
Nelson, van denburg & campbell wealth management group-18.00
Farther finance advisors-80.00
Wr wealth planners-100.00
Quent capital-108.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20253417.24%928,48646.11%828.06%1427.27%6-25.00%
Mar 31, 202529-12.12%635,4734.31%519.84%1157.14%8-65.22%
Dec 31, 20243-94.92%76,616-99.68%-0.02%--100.00%1-96.00%
Sep 30, 202455-21.43%23,175,356-23.61%133.66%12-62.50%2538.89%
Jun 30, 202470-2.78%30,339,56412.37%196.61%3214.29%18-21.74%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.14M2.60%-1.00
Vanguard Total Stock Mkt Idx Inv165.58K1.61%-
Vanguard Institutional Extnd Mkt Idx Tr69.99K0.48%-8.32K
Fidelity Extended Market Index46.32K0.41%-
NT R2000 Index Fund - NL316.31K0.17%-58.09K
NT R2000 Value Index Fund - NL279.80K0.15%-55.32K
NT R2000 Index Fund - DC - NL - 2250.30K0.14%-47.02K
Northern Trust Russell 2000 Value Index249.69K0.14%6.16K
NT R2000 Value Index Fund - L249.69K0.14%6.16K
BlackRock Extended Equity Market K230.77K0.13%-98.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$1.72M
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$2.00M
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$500.00K
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$430.12K
Apr 03, 2019Mazur Leonard L Executive ChairmanBuy$1.80M

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q1--

CTXR Ownership FAQ


Who Owns Citius Pharmaceuticals?

Citius Pharmaceuticals shareholders are primarily institutional investors at 8.44%, followed by 2.90% insiders and 88.66% retail investors. The average institutional ownership in Citius Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Citius Pharmaceuticals falls below.

Who owns the most shares of Citius Pharmaceuticals?

Citius Pharmaceuticals’s largest shareholders are Heights capital management (159.9K shares, 1.45%), Blackrock (1.81M shares, 1.14%), and Northern trust (1.06M shares, 0.66%). Together, they hold 3.25% of Citius Pharmaceuticals’s total shares outstanding.

Does Blackrock own Citius Pharmaceuticals?

Yes, BlackRock owns 1.14% of Citius Pharmaceuticals, totaling 1.81M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.05M$. In the last quarter, BlackRock decreased its holdings by -6.921M shares, a -79.31% change.

Who is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Heights capital management is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.07% of its assets in 159.9K Citius Pharmaceuticals shares, valued at 254.24K$.

Who is the top mutual fund holder of Citius Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Citius Pharmaceuticals shares, with 2.60% of its total shares outstanding invested in 4.14M Citius Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools